Analysis uncovers biochemical heterogeneity in MV1 subtype of CJD, suggesting improved subtyping at pH 6.9 may reveal atypical cases.
. Overall, we propose that MV1 is a more heterogeneous subtype than previously appreciated, potentially existing along a spectrum from MM1-like to VV1-like phenotypes. Importantly, this biochemical heterogeneity may be underrepresented when subtyping is done at pH 8.0, so we recommend CJD subtyping be performed at pH 6.9 to avoid missing atypical or mixed cases.
No takes yet. Share an insight, caveat, or question.
Nemani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: